120 related articles for article (PubMed ID: 7607569)
21. Use of droplet digital PCR for quantitative and automatic analysis of the HER2 status in breast cancer patients.
Otsuji K; Sasaki T; Tanaka A; Kunita A; Ikemura M; Matsusaka K; Tada K; Fukayama M; Seto Y
Breast Cancer Res Treat; 2017 Feb; 162(1):11-18. PubMed ID: 28039535
[TBL] [Abstract][Full Text] [Related]
22. Aberrations of erbB-1 and erbB-2 oncogenes in non-dysplastic leukoplakias of the oral cavity.
Werkmeister R; Brandt B; Joos U
Br J Oral Maxillofac Surg; 1999 Dec; 37(6):477-80. PubMed ID: 10687911
[TBL] [Abstract][Full Text] [Related]
23. [Amplification of oncogenes HER2, mdm-2 and myc in breast cancer determined by modified competitive PCR].
Deng GR; He LW; Lu YY
Zhonghua Yi Xue Za Zhi; 1995 Feb; 75(2):100-3, 127. PubMed ID: 7767763
[TBL] [Abstract][Full Text] [Related]
24. Critical determination of the frequency of c-erbB-2 amplification in breast cancer.
Hubbard AL; Doris CP; Thompson AM; Chetty U; Anderson TJ
Br J Cancer; 1994 Sep; 70(3):434-9. PubMed ID: 7915911
[TBL] [Abstract][Full Text] [Related]
25. Rapid quantitative analysis of differential PCR products by high-performance liquid chromatography.
Zeillinger R; Schneeberger C; Speiser P; Kury F
Biotechniques; 1993 Jul; 15(1):89-95. PubMed ID: 8103348
[TBL] [Abstract][Full Text] [Related]
26. Determination of amplification level of the c-erbB-2 proto-oncogene in human breast carcinomas: a comparative study between non-radioactive and radioactive labelling.
Edorh A; Parache RM; N'Sossani B; Bottin MC; Merlin JL; Colosetti P; Guillemin F; Le Faou A; Rihn B
Cell Mol Biol (Noisy-le-grand); 1995 Nov; 41(7):967-73. PubMed ID: 8595375
[TBL] [Abstract][Full Text] [Related]
27. Analysis of gene amplification in archival tissue by differential polymerase chain reaction.
Neubauer A; Neubauer B; He M; Effert P; Iglehart D; Frye RA; Liu E
Oncogene; 1992 May; 7(5):1019-25. PubMed ID: 1349162
[TBL] [Abstract][Full Text] [Related]
28. The significance of HER-2/neu/c-erbB-2 gene amplification in benign and malignant breast disease.
Supanaranond K; Sukarayodhin S; Tanyakaset M; Balachandra K; Jullaksorn D; Rienkijkarn M; Hoisanka N; Tantivanich S
Southeast Asian J Trop Med Public Health; 1997 Sep; 28(3):631-40. PubMed ID: 9561622
[TBL] [Abstract][Full Text] [Related]
29. Significance of c-erbB-2 amplification and DNA aneuploidy. Analysis in 78 patients with node-negative breast cancer.
Babiak J; Hugh J; Poppema S
Cancer; 1992 Aug; 70(4):770-6. PubMed ID: 1353701
[TBL] [Abstract][Full Text] [Related]
30. Oncogene profile of papillary thyroid carcinoma.
Sugg SL; Ezzat S; Zheng L; Freeman JL; Rosen IB; Asa SL
Surgery; 1999 Jan; 125(1):46-52. PubMed ID: 9889797
[TBL] [Abstract][Full Text] [Related]
31. Multiple genetic lesions in laryngeal squamous cell carcinomas.
Fracchiolla NS; Pignataro L; Capaccio P; Trecca D; Boletini A; Ottaviani A; Polli E; Maiolo AT; Neri A
Cancer; 1995 Mar; 75(6):1292-301. PubMed ID: 7882279
[TBL] [Abstract][Full Text] [Related]
32. Gene amplification for c-erbB-2, c-myc, epidermal growth factor receptor, int-2, and N-myc measured by quantitative PCR with a multiple competitor template.
Sestini R; Orlando C; Zentilin L; Lami D; Gelmini S; Pinzani P; Giacca M; Pazzagli M
Clin Chem; 1995 Jun; 41(6 Pt 1):826-32. PubMed ID: 7768000
[TBL] [Abstract][Full Text] [Related]
33. [The significance of c-erbB-2 and int-2 gene alterations and DNA ploidy pattern for aggressiveness of breast cancer].
Nagayama K; Watatani M; Maeda S; Imanishi Y; Kurooka K; Wada T; Yasutomi M
Nihon Geka Gakkai Zasshi; 1993 Oct; 94(10):1144-52. PubMed ID: 7901748
[TBL] [Abstract][Full Text] [Related]
34. The profile of ErbB/Her family genes copy number assessed by real-time PCR in parathyroid adenoma and hyperplasia associated with sporadic primary hyperparathyroidism.
Bednarz N; Błaut K; Sworczak K; Oseka T; Bielawski KP
Acta Biochim Pol; 2009; 56(1):83-8. PubMed ID: 19259547
[TBL] [Abstract][Full Text] [Related]
35. Quantification of c-erbB-2 gene expression in breast cancer by competitive RT-PCR.
Révillion F; Hornez L; Peyrat JP
Clin Chem; 1997 Nov; 43(11):2114-20. PubMed ID: 9365396
[TBL] [Abstract][Full Text] [Related]
36. c-erbB-2 amplification in node-negative human breast cancer.
Ro JS; el-Naggar A; Ro JY; Blick M; Frye D; Fraschini G; Fritsche H; Hortobagyi G
Cancer Res; 1989 Dec; 49(24 Pt 1):6941-4. PubMed ID: 2573424
[TBL] [Abstract][Full Text] [Related]
37. Amplification of ERBB-2 (HER-2/NEU) oncogene in different neoplasms of patients from USSR.
Knyazev PG; Imyanitov EN; Chernitca OI; Nikiforova IF; Hanson KP
Oncology; 1992; 49(2):162-5. PubMed ID: 1349430
[TBL] [Abstract][Full Text] [Related]
38. The c-erbB-2 oncogene amplification by competitive PCR in aneuploid cell clones flow sorted from breast cancer samples.
Vona G; Caldini A; Sestini R; Rapi S; Bianchi S; Fanelli A; Pazzagli M; Orlando C
Clin Chem Lab Med; 1999 Jun; 37(6):649-54. PubMed ID: 10475073
[TBL] [Abstract][Full Text] [Related]
39. Detection of c-erbB-2/neu and fibroblast growth factor-3/INT-2 but not epidermal growth factor receptor gene amplification in endometrial cancer by differential polymerase chain reaction.
Esteller M; García A; Martínez i Palones JM; Cabero A; Reventós J
Cancer; 1995 Apr; 75(8):2139-46. PubMed ID: 7697605
[TBL] [Abstract][Full Text] [Related]
40. Detection of breast cancer micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Comparison between MUC1 mRNA and keratin 19 mRNA amplification.
Noguchi S; Aihara T; Motomura K; Inaji H; Imaoka S; Koyama H
Am J Pathol; 1996 Feb; 148(2):649-56. PubMed ID: 8579127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
